The history of diversity in clinical trial populations tells a stark story about medical research in America. Despite decades of regulatory pressure, clinical trials too often exclude some of the very populations they’re meant to serve. Women, members of racial and ethnic minority groups, rural patients, and older adults remain significantly underrepresented in studies that determine whether new drugs and devices work — and for whom.
